Metabolic regulation of stem cell niche development and function
干细胞生态位发育和功能的代谢调节
基本信息
- 批准号:10416234
- 负责人:
- 金额:$ 50.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdipocytesAdultAnatomyAnimalsB-LymphocytesBioenergeticsBirthBloodBlood CellsBone MarrowBone Marrow InvolvementCell Cycle ArrestCell LineageCell surfaceCellsCellular Metabolic ProcessDataDefectDevelopmentEmbryonic DevelopmentFailureFatty AcidsFermentationFetal LiverGlucoseGlycolysisHematological DiseaseHematologyHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHomingHumanImpairmentInvestigationKnock-outKnockout MiceKnowledgeLimb BudLiverLymphoidMaintenanceMarrowMediatingMesenchymalMetabolicMetabolic stressMetabolismMitochondriaMitochondrial ProteinsModelingMolecularMusMyelogenousNIH Program AnnouncementsOsteoblastsOxidative PhosphorylationPTPRC genePeptidesPerinatalPhosphatidylinositol PhosphatesPhosphoric Monoester HydrolasesPlayPopulationProcessProteinsPyruvateRegimenRegulationResearchRoleSignaling MoleculeStem cell transplantStressStromal CellsSupporting CellTestingTimebasecell regenerationcell typechemokinechemotherapycytokineextracellularhematopoietic stem cell nicheimprovedmigrationmitochondrial metabolismnestin proteinosteoprogenitor celloxidationperinatal developmentpreconditioningprecursor cellprogenitorreconstructionresponsestem cell biologystem cell nichestem cellstransplantation therapy
项目摘要
Project Summary
Hematopoietic stem cells (HSCs) and progenitors are tightly regulated by both cell intrinsic mechanisms and the
microenvironment (also known as niches) created by specialized bone marrow (BM) stromal cells. However,
how stem cell or progenitor niches are developed, maintained, and remodeled in response to stress is poorly
characterized. Lack of such fundamental knowledge hinders our ability to understand certain hematological
diseases directly or indirectly involving the BM microenvironment. HSCs, the precursor cells that give rise to all
blood lineages, are maintained in discrete anatomical microenvironments during embryonic development, and
they ultimately migrate from the fetal liver to the BM (“homing”) at the perinatal stage. Yet our understanding of
the mechanisms regulating this process remains limited. We previously demonstrated a crucial cell-intrinsic role
of PTPMT1, a mitochondria-based Pten-like phosphatidylinositol phosphate phosphatase, in hematopoietic cell
development − Knockout of PTPMT1 from the hematopoietic system resulted in hematopoietic failure due to the
bioenergetic/metabolic stress, cell cycle arrest, and differentiation block of HSCs. Using the PTPMT1 knockout
model, we recently examined the role of coordinated cellular metabolism in the stem cell microenvironment by
generating and characterizing PTPMT1fl/fl/Prx1-Cre+ mice, in which PTPMT1 was deleted from BM stromal cells
(and limb bud progenitor-derived other mesenchymal cells). Surprisingly, deletion of PTPMT1 from BM stromal
cells resulted in profound hematopoietic defects: 1). Nearly eighty percent of PTPMT1fl/fl/Prx1-Cre+ mice died
within 3 weeks of birth. The migration/homing of HSCs (wild-type) from the fetal liver to the BM was impaired in
these animals – HSCs in the BM of knockout mice decreased by ~5-fold compared to those in control mice 2
weeks after birth, while there were ~13 times more hematopoietic foci (CD45+) in the liver of knockout mice. 2).
B lymphocyte development was blocked in the pro-B stage in PTPMT1fl/fl/Prx1-Cre+ mice. These striking
observations led us to hypothesize that PTPMT1-mediated metabolism plays an important role in establishing or
maintaining supportive stem cell niches in the BM. The objective of the current proposal is to further determine
the underlying cellular and molecular mechanisms. By studying this particular mitochondrial protein, we aim to
decipher the metabolic regulation of HSC niche development/maintenance/remodeling. We plan to test our
hypothesis by pursuing the following three aims. 1). To identify the niche cells in which PTPMT1 depletion-
induced bioenergetic/metabolic stress causes HSC homing defects during perinatal development. 2). To
determine the functional relevance of PTPMT1-mediated metabolism in HSC niche cells to steady-state and
stress hematopoiesis in adults. 3). To identify the bioactive molecules that account for the effects of PTPMT1-
depletion from the niche on HSCs, and the mechanisms by which PTPMT1 deficiency reprograms cellular
metabolism.
项目概要
造血干细胞 (HSC) 和祖细胞受到细胞内在机制和造血干细胞的严格调控。
由专门的骨髓 (BM) 基质细胞创建的微环境(也称为生态位)。然而,
干细胞或祖细胞生态位如何开发、维持和重塑以应对压力尚不清楚
特点。缺乏这些基础知识会阻碍我们理解某些血液学的能力
直接或间接涉及骨髓微环境的疾病。 HSC,是产生所有细胞的前体细胞
血统,在胚胎发育过程中维持在离散的解剖微环境中,并且
它们最终在围产期从胎儿肝脏迁移到BM(“归巢”)。然而我们的理解
调节这一过程的机制仍然有限。我们之前证明了至关重要的细胞内在作用
PTPMT1(一种基于线粒体的 Pten 样磷脂酰肌醇磷酸酶)在造血细胞中的表达
发育 − 从造血系统中敲除 PTPMT1 导致造血功能衰竭
生物能/代谢应激、细胞周期停滞和 HSC 分化阻断。使用 PTPMT1 敲除
模型中,我们最近通过以下方法研究了协调细胞代谢在干细胞微环境中的作用
生成并表征 PTPMT1fl/fl/Prx1-Cre+ 小鼠,其中 PTPMT1 从 BM 基质细胞中删除
(以及肢芽祖细胞衍生的其他间充质细胞)。令人惊讶的是,从 BM 基质中删除 PTPMT1
细胞导致严重的造血缺陷:1)。近 80% 的 PTPMT1fl/fl/Prx1-Cre+ 小鼠死亡
出生后3周内。 HSC(野生型)从胎儿肝脏到 BM 的迁移/归巢受到损害
这些动物 – 与对照小鼠相比,基因敲除小鼠的 BM 中的 HSC 减少了约 5 倍 2
出生后几周,基因敲除小鼠肝脏中的造血灶(CD45+)数量增加了约 13 倍。 2)。
PTPMT1fl/fl/Prx1-Cre+ 小鼠的 B 淋巴细胞发育在 pro-B 阶段被阻断。这些引人注目的
观察结果使我们推测 PTPMT1 介导的代谢在建立或
维持骨髓中的支持性干细胞生态位。当前提案的目标是进一步确定
潜在的细胞和分子机制。通过研究这种特殊的线粒体蛋白,我们的目标是
破译 HSC 生态位发育/维持/重塑的代谢调节。我们计划测试我们的
假设通过追求以下三个目标。 1)。鉴定 PTPMT1 缺失的利基细胞
诱导的生物能/代谢应激导致围产期发育期间 HSC 归巢缺陷。 2)。到
确定 HSC 微环境细胞中 PTPMT1 介导的代谢与稳态和稳态的功能相关性
成人应激造血。 3)。鉴定导致 PTPMT1 作用的生物活性分子
HSC 上的生态位耗尽,以及 PTPMT1 缺陷重新编程细胞的机制
代谢。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHENG-KUI QU其他文献
CHENG-KUI QU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHENG-KUI QU', 18)}}的其他基金
Targeting leukemic stem cells in acute myeloid leukemia
靶向治疗急性髓系白血病的白血病干细胞
- 批准号:
10561291 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Eradicating leukemic stem cells in juvenile myelomonocytic leukemia
根除幼年粒单核细胞白血病中的白血病干细胞
- 批准号:
10722045 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Metabolic regulation of stem cell niche development and function
干细胞生态位发育和功能的代谢调节
- 批准号:
10581643 - 财政年份:2022
- 资助金额:
$ 50.86万 - 项目类别:
Synthetic lethality in leukemic stem cells in juvenile myelomonocytic leukemia
幼年型粒单核细胞白血病干细胞的综合致死率
- 批准号:
10308711 - 财政年份:2020
- 资助金额:
$ 50.86万 - 项目类别:
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment
干细胞微环境中 PTPN11 (SHP2) 的种系突变
- 批准号:
10208202 - 财政年份:2016
- 资助金额:
$ 50.86万 - 项目类别:
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment
干细胞微环境中 PTPN11 (SHP2) 的种系突变
- 批准号:
10369684 - 财政年份:2016
- 资助金额:
$ 50.86万 - 项目类别:
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment
干细胞微环境中 PTPN11 (SHP-2) 的种系突变
- 批准号:
9174534 - 财政年份:2016
- 资助金额:
$ 50.86万 - 项目类别:
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment
干细胞微环境中 PTPN11 (SHP2) 的种系突变
- 批准号:
10642661 - 财政年份:2016
- 资助金额:
$ 50.86万 - 项目类别:
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment
干细胞微环境中 PTPN11 (SHP-2) 的种系突变
- 批准号:
9327048 - 财政年份:2016
- 资助金额:
$ 50.86万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 50.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
- 批准号:
10334113 - 财政年份:2022
- 资助金额:
$ 50.86万 - 项目类别:














{{item.name}}会员




